ArticleNature human behaviour2022
Strategic COVID-19 vaccine distribution can simultaneously elevate social utility and equity.
Article in Nature human behaviour, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.
- A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV.Nature human behaviour · 2024Pooled it
- A Global Intra-city Commuting Origin-Destination Flow Dataset for Urban Sustainable Development.Scientific data · 2026Article
- Optimizing vaccination scheduling during influenza outbreaks: a SEIAR-based model for balancing routine and emergency vaccination demands.Frontiers in public health · 2026Article
- Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Equity considerations in COVID-19 vaccine allocation modelling: a methodological study.Interface focus · 2025Review
- Spatial data intelligence and city metaverse: A review.Fundamental research · 2025Review
- Using human mobility data to quantify experienced urban inequalities.Nature human behaviour · 2025Review
- MetaCity: Data-driven sustainable development of complex cities.Innovation (Cambridge (Mass.)) · 2025Review
- To vaccinate or not to vaccinate? Dark triad personality traits in the context of decision about vaccination against COVID-19.Frontiers in psychiatry · 2025Article
- Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review.Human vaccines & immunotherapeutics · 2024Review
- Online bilateral matching methodology for anti-epidemic resources based on spatial transmission risk.Scientific reports · 2024Article
- Evaluating equity-promoting interventions to prevent race-based inequities in influenza outcomes.medRxiv : the preprint server for health sciences · 2024Article
- Incorporating social determinants of health into transmission modeling of COVID-19 vaccine in the US: a scoping review.Lancet regional health. Americas · 2024Article
- How enlightened self-interest guided global vaccine sharing benefits all: A modeling study.Journal of global health · 2023Article
- Retrospective analysis of equity-based optimization for COVID-19 vaccine allocation.PNAS nexus · 2023Article
- Retrospective Analysis of Equity-Based Optimization for COVID-19 Vaccine Allocation.medRxiv : the preprint server for health sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 6 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Balancing social utility and equity in distributing limited vaccines is a critical policy concern for protecting against the prolonged COVID-19 pandemic and future health emergencies. What is the nature of the trade-off between maximizing collective welfare and minimizing disparities between more and less privileged communities? To evaluate vaccination strategies, we propose an epidemic model that explicitly accounts for both demographic and mobility differences among communities and their associations with heterogeneous COVID-19 risks, then calibrate it with large-scale data. Using this model, we find that social utility and equity can be simultaneously improved when vaccine access is prioritized for the most disadvantaged communities, which holds even when such communities manifest considerable vaccine reluctance. Nevertheless, equity among distinct demographic features may conflict; for example, low-income neighbourhoods might have fewer elder citizens. We design two behaviour-and-demography-aware indices, community risk and societal risk, which capture the risks communities face and those they impose on society from not being vaccinated, to inform the design of comprehensive vaccine distribution strategies. Our study provides a framework for uniting utility and equity-based considerations in vaccine distribution and sheds light on how to balance multiple ethical values in complex settings for epidemic control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.